Resonetics Expands Manufacturing Solutions through Eden Holdings Acquisition

Resonetics, a key player in the medical device industry, recently made headlines by announcing its acquisition of Eden Holdings, which includes Eden Manufacturing and Eden Tool. This strategic move enriches Resonetics' portfolio by integrating sophisticated injection molding and micro machining capabilities essential for producing critical medical devices.

The acquisition significantly strengthens Resonetics’ technical strengths, adding precision services such as micro-molding, insert-molding, and advanced machining and tooling to its existing metal processing capabilities. With a focused expansion, the added services aim to fuel growth in areas like robotic surgery, minimally invasive surgery, and electrophysiology, all of which are witnessing a surge in demand.

Founded in 2000, Eden Holdings has established itself as a reputable manufacturer specializing in injection molding solutions, particularly within the MedTech field. Renowned for its precision tooling, Eden has transitioned its expertise into high-precision micro and insert molding while maintaining a commitment to delivering molds and components tailored to the stringent requirements of leading MedTech OEMs.

Eden also exhibits profound capabilities in Class 101 production tooling, emphasizing the necessity for uncompromising precision in manufacturing components that have complex geometries. Its seasoned approach to mold design ensures reliable and consistent solutions that meet the demanding standards set by key industry players.

In sharing insights on the acquisition, Resonetics CEO, Kevin Kelly, emphasized how the integration of Eden's capabilities enables Resonetics to provide more comprehensive solutions across diverse materials and technologies. He stated, “With the addition of Eden, we are enhancing our ability to deliver integrated solutions across materials and technologies. Eden’s strength in injection molding and precision tooling is a critical addition that complements our metal processing expertise across our entire portfolio.”

David Tomic, President of Eden, echoed similar sentiments, stating that joining Resonetics opens access to global resources aimed at better serving customers. He expressed excitement over combining their advanced expertise in precision tooling and manufacturing with Resonetics' innovative technologies to create more value in the medical device industry.

The acquisition not only broadens Resonetics' polymer capabilities but also emphasizes their commitment to providing tailored micro-manufacturing solutions for complex medical devices, securing their positioning in a rapidly evolving marketplace.

About Resonetics: Founded in 1987, Resonetics has emerged as a pioneer within the medical device sector, driving innovation through advanced engineering and manufacturing solutions. Their services encompass laser processing, nitinol manufacturing, and photochemical machining, among others, underlining their dedication to quality and customer-centric approaches.

The company operates 17 facilities across North America and Europe, employing over 3,000 staff members globally — a testament to their expansive vision and growth. Backed by significant private equity players, Carlyle and GTCR, Resonetics is steadfast in pursuing innovative advancements and strategic partnerships to remain at the forefront of the industry.

Founded in 1980, GTCR focuses on identifying partnership opportunities that lead to transformative growth within the healthcare and technology sectors. Meanwhile, Carlyle, with assets under management totaling $453 billion as of March 2025, operates across three business segments to invest in industry-leading companies.

To delve deeper into Resonetics’ evolving capabilities and explore how the integration of Eden Holdings will impact the MedTech landscape, be sure to follow their journey and witness a remarkable evolution in manufacturing solutions tailored for medical devices.